Skip to main content

Table 2 Clinical findings and blood test results at the time of nutritional unit outpatient service examination

From: Nutritional management of a patient with obesity and pulmonary embolism: a case report

Blood test results

Variables

Values (Units)

 Hemoglobin

13.4 (g/dl)

 Hematocrit

40.8 (%)

 Mean cellular volume

83.2 (fl)

 Platelets

250 (1000/ μl)

 Leukocytes

8.81 (1000/ μl)

 International normalized ratio

2.06

 Antithrombin III actvity

99 (%)

 D-dimer

378 (μg/l)

 Anti-cardiolipin antibodies

negative

 Anti-beta 2-glycoprotein I antibodies

negative

 Homocysteine

21 (μmol/L)

 Folate

5.8 (ng/ml)

 Vitamin B12

372 (pg/ml)

 Vitamin D

7.4 (ng/ml)

 Parathormone

35.3 (pg/ml)

 Glucose

88(mg/dl)

 Insulin

18.6 (mIU/ml)

 Homeostatic model assessment (HOMA) index

4.04

 Magnesium

2 (mg/dl)

 Prealbumin

0.23 (g/l)

Weight: 93.6 kg

Height: 160 cm

Body mass index: 36.6 kg/m2

aBlood pressure: 120/70 mmHg

Waist circumference: 122 cm

Hip circumference: 118 cm

Waist-to-Hip ratio: 1.03

bResting Energy Expenditure (REE): 1515 kcal/day

cEnergy Expenditure: 1818 kcal/day

dBIA for BC FM = 48.2 % PhA = 5.5°

  1. VR506Q mutation of factor V (Leiden): absent
  2. VH1299R mutation of factor V: absent
  3. G20210 of protrhombin gene (factor II): absent
  4. Methylene tetrahydrofolate reductase (MTHFR) gene mutation: absent
  5. Fifty-two-year old female patient with obesity and hypertension taking anticoagulants due to a history of a recent pulmonary embolism
  6. ataking hypertension medication
  7. bMifflin equation [14].
  8. cEE = REE x Activity Factor Category Definition (1.2 for sedentary)
  9. dBioelectrical Impedance Analysis for Body Composition (BIA 101 Akern s.r.l. – Italy); FM = Fat mass, PhA = Phase angle